Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Subarachnoid hemorrhage, when caused by the rupture of an intracranial aneurysm, has a mortality rate near 50% at 30 days, and approximately half of the survivors sustain irreversible brain damage. To avoid such a catastrophic event, it is important to identify and treat patients who harbor aneurysms that carry a significant risk of rupture. With the increased use of brain imaging in recent medical practice, including noninvasive tests like computed tomography (CT) and magnetic resonance (MR) angiography (MRA), a growing number of unruptured and usually asymptomatic intracranial aneurysms are being diagnosed. The decision of whether such lesions should be treated, and if so, whether by surgical or endovascular therapy, has been the subject of great controversy. This chapter evaluates the data available for making management decisions for unruptured aneurysms.
Intracranial aneurysms are common and may generally be classified as saccular (hemodynamic or “berry”) and fusiform (dissecting, infectious, arteriosclerotic, or traumatic) types. The saccular type is by far the most common and is the focus of this chapter. Autopsy studies have shown that the overall prevalence of intracranial aneurysms in the general population ranges from 0.2% to 9.9%. The population-based incidence of aneurysmal subarachnoid hemorrhage varies from 6 to 21.6 cases per 100,000 persons per year.
Study | Year Published | Location | Number of Patients | Study Type | Rupture Predictors |
---|---|---|---|---|---|
Juvela et al. , | 2000, 2013 | Finland | 142 | Retrospective and prospective | Smoking, Acom location, patient age (inversely), aneurysm size |
ISUIA | 1998 | United States, Canada, and Europe | 1449 untreated | Retrospective | Aneurysm size and location, prior SAH |
ISUIA | 2003 | United States, Canada, and Europe | 4060: 1692 untreated | Prospective | Untreated: aneurysm size and location, prior SAH |
SUAVe | 2010 | Japan | 374 | Prospective | Age >50 years, aneurysm diameter ≥4 mm, hypertension and aneurysm multiplicity |
UCAS | 2012 | Japan | 5720 | Prospective | Untreated: aneurysm size and location (acomm, pcomm), presence of daughter sac |
Ishibashi et al. | 2009 | Japan | 419 | Prospective | Size, history of SAH, posterior circulation location |
Wermer et al. | 2006 | Netherlands | 93 | Prospective | History of SAH, family history |
Lee et al. | 2012 | South Korea | 7404: 5963 untreated | Prospective | Untreated Older age |
The decision of whether to treat an unruptured aneurysm is based on the likelihood of its rupture during the patient’s lifetime. The natural history study with the longest follow-up comes from Helsinki, Finland, where Juvela and colleagues reviewed a series of 142 patients with unruptured aneurysms followed without treatment from 1956 to 198 (median follow-up of 19.7 years). An advantage of the study is that it avoids treatment selection bias, because no unruptured aneurysms were treated in Helsinki before 1979. During 2575 person-years, 33 of the 142 patients (23%) had subarachnoid hemorrhage, resulting in an annual rupture rate of 1.3%. The cumulative rates of rupture were 10.5% at 10 years, 23% at 20 years, and 30.3% at 30 years. Twenty-nine of 33 aneurysms that eventually ruptured were smaller than 10 mm in diameter at the time of the original diagnosis (18 were ≤6 mm). , , Those aneurysms that ruptured were more likely to have increased in size (≥1 mm) compared to those that did not rupture. Notably, the majority of the patients (131 of 142) had previous subarachnoid hemorrhage from another aneurysm, thus comprising a group of patients which may have had a higher rupture rate compared to those with no prior history of subarachnoid hemorrhage. Nevertheless, the study by Juvela and colleagues provided substantial long-term data on the natural history of unruptured aneurysms, and the annual rupture rate of 1.3% was similar to previously published reports (1% to 2.3%).
Between 1976 and 1997, Tsutsumi and colleagues observed 62 patients who had noncalcified unruptured intradural aneurysms and no prior history of subarachnoid hemorrhage. For small aneurysms (<10 mm), the 5- and 10-year rupture risks were 4.5% and 13.9%, respectively, an annual rupture rate similar to that reported by Juvela and colleagues. , , For large aneurysms (>10 mm), the 5- and 10-year rupture risks were several-fold higher, 33.5% and 55.9%, respectively.
From 2003 to 2006, Ishibashi and colleagues elected to observe unruptured intracranial aneurysms at their institution. Of a total of 419 patients with 529 aneurysms, 19 aneurysms ruptured during the observation period, resulting in a 1.4% annual rupture rate. Eight of the 19 aneurysms that ruptured were under 5 mm in size.
In 1998, a large retrospective international study, Phase I of the International Study of Unruptured Intracranial Aneurysms (ISUIA), evaluated the natural history of 1937 unruptured aneurysms in 1449 patients. Patients harboring at least one unruptured aneurysm were divided into two groups: those with no history of subarachnoid hemorrhage (group 1) and those with a history of subarachnoid hemorrhage from another aneurysm (group 2). Patients in these two groups were not selected for surgical repair for various and often unknown reasons. The mean duration of follow-up was 8.3 years. As shown in Table 42.2 , for aneurysms smaller than 10 mm, the annual rupture rate was 0.05% in group 1 (727 patients) and 0.5% in group 2 (722 patients). For aneurysms 10 to 24 mm in size, the annual rupture rate was approximately 1% in both groups. For giant aneurysms (25 mm or larger), the rupture rate was 6% in the first year and declined thereafter. Aneurysms of the posterior circulation (the vertebrobasilar system) were significantly more likely to rupture than aneurysms of the anterior circulation, with basilar apex aneurysms carrying a relative risk of 13.8 compared to other locations. The study concluded that small unruptured aneurysms, particularly those in the anterior circulation with no history of prior aneurysmal subarachnoid hemorrhage, should be left untreated, especially when the morbidity and mortality rates of surgical repair were considered. This study generated significant controversy because its results were substantially different from previously published reports of a 1% to 2% annual rupture risk. ,
<10 mm | 10–24 mm | ≥25 mm | |||
Group 1 | Group 2 | ||||
ISUIA I | 0.05% | 0.5% | 1% | 6% | |
ISUIA II | <7 mm | 7–12 mm | 13–24 mm | ≥25 mm | |
Group 1 | Group 2 | ||||
Anterior circulation | 0 | 0.3% | 0.5% | 2.9% | 8% |
Posterior circulation (including Pcom) | 0.5% | 0.7% | 2.9% | 3.7% | 10% |
In 2003, prospective data from the ISUIA was published as Phase II. Aneurysms in this study were categorized by size into four groups: under 7 mm, 7 to 12 mm, 13 to 24 mm, and 25 mm or larger. Noncavernous anterior circulation aneurysms had 5-year cumulative rupture rates of 0% to 1.5%, 2.6%, 14.5%, and 40%, by size category, respectively. Posterior circulation aneurysms (including [Pcom] aneurysms, which are usually considered part of the anterior circulation) had cumulative 5-year rupture rates of 2.5%, 14%, 18.4%, and 50%. Although the two ISUIA studies stratified aneurysm size differently, ISUIA II reported rupture rates that were generally higher than ISUIA I (see Table 42.2 ). For aneurysms in the 7- to 10-mm size range, ISUIA II suggested an annual rupture risk (0.5% to 2.9%) that was several-fold greater than the rate of 0.05% to 0.5% purported by ISUIA I, which grouped together all aneurysms under 10 mm in size for the analysis.
Both ISUIA studies have been widely criticized for underestimating the true rupture risk of intracranial aneurysms, and certain limitations may have affected their results:
Selection bias: To be included in either study, a patient first had to be recommended for conservative management by a neurosurgeon. It is quite possible that those aneurysms included in the studies were judged to be very low risk, based on their benign morphology or location (i.e., intracavernous). In ISUIA I, internal carotid artery (ICA) aneurysms represented 42% of the total in group 1 and 27% in group 2; of these, cavernous-segment ICA aneurysms represented 16.9% in group 1 and 9.5% in group 2. In addition, a significant number of patients (32.7% in group 1 and 61.2% in group 2) had very small aneurysms (2 to 5 mm in size) which could also carry a lower rupture risk. Thus the ISUIA I study population included large numbers of patients who harbored intracranial aneurysms considered to have little risk of rupture, at least during the study duration.
Crossover: In both ISUIA phases I and II, some patients who were initially chosen for observation were later advised to have treatment. In phase II, of the 1692 patients in the observation cohort, 534 patients were switched to therapeutic intervention. It is possible that the management strategy changed because of new symptoms or increased aneurysm size, both of which are risk factors for rupture. If those patients were left untreated, the observation cohort rupture rate may have been much higher.
Incomplete follow-up: Mean follow-up for the retrospective phase I study was 8.3 years, and for the prospective phase II study was 4.1 years. Of the 193 patients (11%) who died of causes other than subarachnoid hemorrhage, 52 patients died of intracranial hemorrhage. These patients were excluded from the analysis. It is unknown how these hemorrhages were determined to result from causes other than aneurysm rupture.
Given the disparity between the ISUIA data and other published reports, a population analysis based on prevalence of unruptured aneurysms and incidence of subarachnoid hemorrhage would be helpful. To estimate the prevalence of aneurysms, Winn and colleagues reviewed 3684 cerebral angiography studies performed at the University of Virginia between April 1969 and January 1980. During the pre-CT era, the cerebral angiogram was a commonly performed neuroimaging test for a variety of indications. The authors found 24 asymptomatic unruptured aneurysms in 3684 patients, yielding a prevalence rate of 0.65%. Nearly 80% of the aneurysms were smaller than 10 mm. Because only 53% of the patients underwent a complete angiography study, the authors estimated that the true prevalence ranged from 0.65% to 1.3%. That would mean that in a population of 100,000, between 650 and 1300 people would have an unruptured intracranial aneurysm. Given an annual incidence of subarachnoid hemorrhage of 11 per 100,000 people, a person with an unruptured aneurysm can be estimated to have a 0.85% to 1.7% yearly risk of rupture.
Since ISUIA, a number of other prospective studies on unruptured intracranial aneurysms have been completed. The Unruptured Cerebral Aneurysm Study (UCAS) from Japan prospectively evaluated 5720 patients with unruptured saccular brain aneurysms larger than 3 mm. While this study confirmed findings from ISUIA in terms of aneurysm size and location being predictive of rupture risk, it also demonstrated that anterior communicating artery (ACA) location and presence of a daughter sac increased the likelihood of rupture. This study was significant as it showed that aneurysms in both anterior and posterior communicating arteries ruptured at a relatively high rate even when they were less than 7 mm. While this data pertains to a Japanese population only, it sheds important light on unruptured aneurysm epidemiology.
Another prospective study from Japan (SUAVe: Small Unruptured Aneurysm Verification Study) looked at small unruptured intracranial aneurysms less than 5 mm in 374 patients with 448 aneurysms. Seven patients ruptured during the ensuing 3 and a half years leading to a rupture risk of 0.34% per year in patients with single aneurysms and 0.95% in those with multiple aneurysms. This study found aneurysm multiplicity (with diameter ≥4 mm) to be an independent predictor of rupture in addition to aneurysm diameter, age greater than 50 years, and hypertension.
Lee et al. performed a prospective study in the South Korean population of 7404 patients with unruptured intracranial aneurysms by following them over 3 years. Rupture events occurred in 163 of the 5963 untreated patients leading to a rupture rate of 0.9 cases/100 person years. This study demonstrated highest rupture rate in the first year after unruptured intracranial aneurysm diagnosis and confirmed older age as a risk factor for rupture.
It is now generally accepted that there is a strong correlation between aneurysm size and risk of rupture. ISUIA I used a historical classification scheme to separate aneurysms into small (<10 mm), large (10 to 24 mm), and giant (≥25 mm) categories (ISUIA 1998). ISUIA II separated nongiant aneurysms into three groups: <7 mm, 7 to 12 mm, and 13 to 24 mm (ISUIA 2003). Both studies demonstrated increased rupture rates with larger sizes. The exact size beyond which an aneurysm becomes “dangerous,” however, is unclear. In both clinical and autopsy series, aneurysms that present with hemorrhage are most commonly between 7 and 10 mm in size, and many are smaller than 7 mm. Aneurysms smaller than 7 mm in size account for 55% of the aneurysms that ruptured in Juvela’s series, 58% of the aneurysms that ruptured in the study by Ishibashi and colleagues, and 22% of the aneurysms that ruptured in ISUIA II. , , Initial thoughts that the low risk of rupture of small aneurysms in ISUIA could be due to aneurysms shrinking after rupture did not appear to be true after evaluation of imaging studies before and after rupture.
Rupture of aneurysms smaller than 7 mm was also seen in the UCAS study particularly in the ACA (RR 2.02) and posterior communicating artery (RR 1.9).
Some aneurysms may enlarge prior to rupture, allowing for the premise that unruptured aneurysms can be followed until a change in size is noted. Unfortunately, enlargement may more often occur near the time when the aneurysm ruptures, a quite unpredictable (and potentially fatal) moment.
Both phase I and phase II ISUIA studies showed that posterior circulation aneurysms, especially basilar apex aneurysms, have a higher relative rupture rate compared to those at other sites. , A similar increased risk was also noted for lesions arising from the Pcom artery, a site traditionally considered to be within the anterior circulation. This was also noted in the UCAS study where both anterior and posterior communicating artery location increased the likelihood of rupture. The distribution of aneurysms described in these series differs markedly from that encountered in ruptured aneurysm series. In the ISUIA studies, cavernous and small parasellar ICA aneurysms are highly represented, while in series dealing with ruptured aneurysms, anterior communicating (Acom) and Pcom aneurysm sites predominate. In our personal experience, proximal (paraclinoid) ICA aneurysms are much more common than previously described, and may in fact be the most common aneurysm site, particularly in females. In series of ruptured aneurysms, however, lesions at this site are far less frequent, perhaps indicating that their relationship to and reinforcement by the parasellar dura provides some protection against subarachnoid hemorrhage.
Several reports suggest that aneurysms with irregular morphology, particularly those that are multilobed with daughter domes, have a significantly higher hemorrhage risk compared to smooth-walled, more spherical lesions. , , In the UCAS study, aneurysms with a daughter sac were likely to rupture with a hazard ratio of 1.63 (95% CI 1.08 to 2.48). In recent years, as aneurysm shapes and origins have become more important in determining “coilability,” several quantifiable parameters have been evaluated for their contribution to rupture risk, including aspect ratio, ellipticity index, nonsphericity index, and undulation index. Of these parameters, aspect ratio (aneurysm height/neck width) has correlated best with rupture risk. , Several studies have shown that ruptured aneurysms have higher aspect ratios than unruptured aneurysms, but there is no consensus on a threshold value for increased risk.
With advancements in imaging, study into aneurysm hemodynamics has led to the understanding of processes in the initiation, growth, and rupture of intracranial aneurysms. Wall shear stress (WSS), the frictional force created by blood flow, is thought to lead to aneurysm growth and rupture. In addition to intra-aneurysmal WSS, other hemodynamic parameters such as oscillatory shear index, parent vessel pulsatility index, low WSS area, WSS gradient, number of vortices, and relative resistance time have been studied in relation to aneurysm rupture.
Unruptured aneurysms may present with cranial neuropathy (particularly oculomotor nerve or optic nerve/chiasmal deficits), ischemia, or other symptoms related to mass effect. New nonhemorrhagic symptoms suggest an acute change in the aneurysm (i.e., expansion), indicating a higher risk of imminent rupture compared to asymptomatic lesions. Data supporting this assertion is scant and retrospective, but in general, symptomatic aneurysms are treated with relative urgency, especially small Pcom aneurysms that cause oculomotor deficits.
In families that have multiple members with intracranial aneurysms, an aneurysm’s risk of rupture is higher, and rupture may occur at an earlier age, compared to aneurysms that arise in individuals with no known family history. Familial intracranial aneurysms are discussed later in this chapter.
Phase I of ISUIA showed that a small unruptured aneurysm had a tenfold increase in rupture risk if it occurred in a patient with a history of subarachnoid hemorrhage from a different aneurysm, rather than in a patient with no history of subarachnoid hemorrhage.
Female gender seems to be a risk factor affecting both aneurysm formation and growth, with aneurysms 1.6 times more likely to occur in women than in men. , A series of 1230 autopsies showed two peaks in the prevalence of aneurysms in women, ages 40 to 49 and ages 60 to 69, which correlate with a peak incidence of subarachnoid hemorrhage between ages 40 and 60. Interestingly, in this series, the prevalence of aneurysms in men was unchanged across the range of age groups.
Cigarette smoking may hasten the growth of a preexisting aneurysm, and may contribute to an increased rupture rate, with hemorrhage occurring at smaller sizes. In smokers, there is an increased ratio of elastase to α 1 -antitrypsin in the walls of cerebral arteries, which may contribute to aneurysm formation or rupture. ,
In families in which two people have known intracranial aneurysms, first-degree relatives have a 9% to 11% chance of having an aneurysm in adulthood. Autosomal dominant polycystic kidney disease (ADPKD) is associated with a 15% prevalence of intracranial aneurysms. Genetic conditions with at least some evidence of having an increased incidence of intracranial aneurysms are outlined in Table 42.3 .
Autosomal dominant polycystic kidney disease |
Type IV Ehlers-Danlos syndrome |
Hereditary hemorrhagic telangiectasia |
Neurofibromatosis type 1 |
α 1 -antitrypsin deficiency |
Klinefelter’s syndrome |
Tuberous sclerosis |
Noonan’s syndrome |
α-1,4-glucosidase deficiency |
A number of scoring systems have been devised that can be used in clinical practice by incorporating all the risk factors described above. The two most common ones are the PHASES score and the Unruptured Intracranial Aneurysm Treatment Score (UIATS).
The PHASES score was derived after pooled analysis of six prospective cohort studies with unruptured aneurysms including 8382 patients with subarachnoid hemorrhage as outcome. The mean rupture risk at 1 year was 1.4% (95% CI 1.1 to 1.6) and at 5 years was 3.4% (2.9 to 4.0). The key predictors for aneurysm rupture identified after this pooled analysis included age, hypertension, history of subarachnoid hemorrhage, aneurysm size, aneurysm location, and geographical region. A score of zero to 22 is hence possible on this scoring scheme ( Table 42.4 ). A score of zero affords a rupture risk of 0.4% over 5 years while a score of greater than 12 predicts a rupture risk of 17.8% over 5 years. While this scoring system is not perfect given heterogeneity across studies, it provides a useful guide in making decisions in patients with unruptured aneurysms. This analysis however captured every large prospective data on subarachnoid hemorrhage and is the most inclusive of all the tools used for predicting aneurysm rupture. The pooled analysis found no effect of gender, smoking, and aneurysm multiplicity on rupture risk.
PHASES Aneurysm Risk Score | Points | PHASES Risk Score | 5-Year Risk of Aneurysm Rupture | |
---|---|---|---|---|
(P) Population | North American, European (other than Finnish) | 0 | ≤2 | 0.4 (0.1–1.5) |
Japanese | 3 | 3 | 0.7 (0.2–1.5) | |
Finnish | 5 | 4 | 0.9 (0.3–2.0) | |
(H) Hypertension | No | 0 | 5 | 1.3 (0.8–2.4) |
Yes | 1 | 6 | 1.7 (1.1–2.7) | |
(A) Age | <70 years old | 0 | 7 | 2.4 (1.6–3.3) |
≥70 years old | 1 | 8 | 3.2 (2.3–4.4) | |
(S) Size of aneurysm | <7.0 mm | 0 | 9 | 4.3 (2.9–6.1) |
7.0–9.9 mm | 3 | 10 | 5.3 (3.5–8.0) | |
10.0–19.9 mm | 6 | 11 | 7.2 (5.0–10.2) | |
≥20 mm | 10 | ≥12 | 17.8 (15.2–20.7) | |
(E) Earlier SAH from another aneurysm | No | 0 | ||
Yes | 1 | |||
(S) Site of aneurysm | ICA | 0 | ||
MCA | 2 | |||
ACA/PcomA/Posterior | 4 |
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here